Shitara K - Search Results

1

Efficacy of Pembrolizumab Monotherapy for Advanced Gastric/Gastroesophageal Junction Cancer with Programmed Death Ligand 1 Combined Positive Score ≥10.

Wainberg ZA, Fuchs CS, Tabernero J, Shitara K, Muro K, Van Cutsem E, Bang YJ, Chung HC, Yamaguchi K, Varga E, Chen JS, Hochhauser D, Thuss-Patience P, Al-Batran SE, Garrido M, Kher U, Shih CS, Shah S, Bhagia P, Chao J. Wainberg ZA, et al. Among authors: shitara k. Clin Cancer Res. 2021 Apr 1;27(7):1923-1931. doi: 10.1158/1078-0432.CCR-20-2980. Epub 2021 Jan 14. Clin Cancer Res. 2021. PMID: 33446564 Clinical Trial.

2

Chemotherapy for gastric cancer that recurs after adjuvant chemotherapy with S-1.

Shitara K, Muro K, Ura T, Takahari D, Yokota T, Sawaki A, Kawai H, Ito S, Yamamura Y. Shitara K, et al. Jpn J Clin Oncol. 2008 Nov;38(11):786-9. doi: 10.1093/jjco/hyn096. Epub 2008 Sep 26. Jpn J Clin Oncol. 2008. PMID: 18820010

3

Neutropaenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX.

Shitara K, Matsuo K, Takahari D, Yokota T, Inaba Y, Yamaura H, Sato Y, Najima M, Ura T, Muro K. Shitara K, et al. Eur J Cancer. 2009 Jul;45(10):1757-63. doi: 10.1016/j.ejca.2009.01.019. Epub 2009 Feb 11. Eur J Cancer. 2009. PMID: 19217278

4

[Molecular targeted therapy in colorectal cancer and its resistance].

Shitara K, Muro K. Shitara K, et al. Gan To Kagaku Ryoho. 2009 Apr;36(4):557-66. Gan To Kagaku Ryoho. 2009. PMID: 19381027 Japanese.

5

Chemoradiotherapy for treatment of esophageal cancer in Japan: current status and perspectives.

Shitara K, Muro K. Shitara K, et al. Gastrointest Cancer Res. 2009 Mar;3(2):66-72. Gastrointest Cancer Res. 2009. PMID: 19461908 Free PMC article.

6

Association of prostate stem cell antigen gene polymorphisms with the risk of stomach cancer in Japanese.

Matsuo K, Tajima K, Suzuki T, Kawase T, Watanabe M, Shitara K, Misawa K, Ito S, Sawaki A, Muro K, Nakamura T, Yamao K, Yamamura Y, Hamajima N, Hiraki A, Tanaka H. Matsuo K, et al. Among authors: shitara k. Int J Cancer. 2009 Oct 15;125(8):1961-4. doi: 10.1002/ijc.24519. Int J Cancer. 2009. PMID: 19582881 Free article.

7

Phase II study of combination chemotherapy with irinotecan and cetuximab for pretreated metastatic colorectal cancer harboring wild-type KRAS.

Shitara K, Yokota T, Takahari D, Shibata T, Ura T, Utsunomiya S, Inaba Y, Yamaura H, Sato Y, Najima M, Kawai H, Tajika M, Sawaki A, Yatabe Y, Muro K. Shitara K, et al. Invest New Drugs. 2011 Aug;29(4):688-93. doi: 10.1007/s10637-009-9382-x. Epub 2010 Jan 14. Invest New Drugs. 2011. PMID: 20072801 Clinical Trial.

8

Was the unexpected result a response to reintroduction of effective chemotherapy?

Shitara K, Muro K. Shitara K, et al. Gastrointest Cancer Res. 2009 Sep;3(5):217-8. Gastrointest Cancer Res. 2009. PMID: 20084166 Free PMC article. No abstract available.

9

Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis: a retrospective study.

Shitara K, Matsuo K, Hatooka S, Ura T, Takahari D, Yokota T, Abe T, Kawai H, Tajika M, Kodaira T, Shinoda M, Tajima K, Muro K, Tanaka H. Shitara K, et al. Cancer Sci. 2010 Apr;101(4):1001-6. doi: 10.1111/j.1349-7006.2009.01466.x. Epub 2009 Dec 9. Cancer Sci. 2010. PMID: 20085588 Free article.

10

Histological subtype of gastric cancer in Japan.

Shitara K, Muro K. Shitara K, et al. Lancet Oncol. 2010 Feb;11(2):115-6. doi: 10.1016/S1470-2045(09)70367-5. Lancet Oncol. 2010. PMID: 20152767 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

446 results

Search Page